Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Many of the neuromuscular (e.g., muscular dystrophy) and neurometabolic (e.g., mitochondrial cytopathies) disorders share similar final common pathways of cellular dysfunction that may be favorably influenced by creatine monohydrate (CrM) supplementation. Studies using the mdx model of Duchenne muscular dystrophy have found evidence of enhanced mitochondrial function, reduced intra-cellular calcium and improved performance with CrM supplementation. Clinical trials in patients with Duchenne and Becker's muscular dystrophy have shown improved function, fat-free mass, and some evidence of improved bone health with CrM supplementation. In contrast, the improvements in function in myotonic dystrophy and inherited neuropathies (e.g., Charcot-Marie-Tooth) have not been significant. Some studies in patients with mitochondrial cytopathies have shown improved muscle endurance and body composition, yet other studies did not find significant improvements in patients with mitochondrial cytopathy. Lower-dose CrM supplementation in patients with McArdle's disease (myophosphorylase deficiency) improved exercise capacity, yet higher doses actually showed some indication of worsened function. Based upon known cellular pathologies, there are potential benefits from CrM supplementation in patients with steroid myopathy, inflammatory myopathy, myoadenylate deaminase deficiency, and fatty acid oxidation defects. Larger randomized control trials (RCT) using homogeneous patient groups and objective…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been known for a long time that creatine supplementation possesses neuroprotective benefits”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [38]
In the citing paper
“To date, the majority of clinical trials investigating the therapeutic potential of creatine supplementation in pediatric populations have focused on creatine (and/or creatine transporter) deficiencies, inborn errors of metabolism, neuromuscular disorders, and myopathies [9,44,45,46,47,48,49].”
From Creatine Supplementation in Children and Adolescents (2021) · cites this paper as [46]
In the citing paper
“the CK/PCr system thereby serves as an important regulator of metabolism which may help explain the ergogenic and potential therapeutic health benefits of creatine supplementation”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [38]
In the citing paper
“there is evidence from animal models that creatine supplementation is neuroprotective [147–149] and can reduce the severity of spinal cord injury [150, 151], cerebral ischemia [152–155], and concussion/traumatic brain injury [2, 7, 12, 22, 32, 33, 156].”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [149]
In the citing paper
“The role of creatine in energy metabolism and impact that creatine has on maintaining energy availability in diseases that depend on the CK/PCr system provides the metabolic basis on how creatine can affect health, disease, and provide therapeutic benefit [6,9,21,41,50,64,65,66,67,68,69,70,71].”
From Creatine in health and disease (2021) · cites this paper as [64]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mitochondria, oxygen free radicals, disease and ageing
Raha, S., & Robinson, B. H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01674-1 · Cited by 1,066 · cited 1×
“Mitochondrial disorders are associated with a reduction in aerobic ATP production and stores, increased utilization of anaerobic energy sources, and an increase in oxidative stress (Piccolo et al., 1991; Raha and Robinson, 2000; Tarnopolsky and Beal, 2001; Tarnopolsky and Parise, 1999).”
BackgroundNeuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682
Clinical trial in duchenne dystrophy. I. The design of the protocol
Brooke, M. H., Griggs, R. C., Mendell, J. R., Fenichel, G. M., Shumate, J. B., & Pellegrino, R. J. (1981) · Muscle & Nerve · doi:10.1002/mus.880040304 · Cited by 564
AAEM minimonograph #26: The electrodiagnosis of carpal tunnel syndrome
Stevens, J. C. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199712)20:12 · Cited by 518
Self-citationClinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease
Scaglia, F., Towbin, J. A., Craigen, W. J., Belmont, J. W., Smith, E. O., Neish, S. R., Ware, S. M., Hunter, J. V., Fernbach, S. D., Vladutiu, G. D., et al. (2004) · Pediatrics · doi:10.1542/peds.2004-0718 · Cited by 466 · cited 1×
“Cardiomyopathy appears to be one of the more ominous signs in mitochondrial cytopathies, for its development is a negative predictive factor for survival (Scaglia et al., 2004).”
BackgroundDirect antioxidant properties of creatine
Lawler, J. M., Barnes, W. S., Wu, G., Song, W., & Demaree, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6164 · Cited by 448 · cited 1×
“A number of studies have demonstrated that CrM supplementation can lead to a reduction in markers of oxidative stress in a variety of tissues, especially the central nervous system (Adcock et al., 2002; Andreassen et al., 2001; Klivenyi et al., 1999, 2004; Lawler et al., 2002; Malcon et al., 2000; Sullivan et al., 200…”
BackgroundPhysiological and Health Effects of Oral Creatine Supplementation
(2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200003000-00024 · Cited by 413 · cited 4×
“Given the potential for creatine to enhance muscle strength (Tarnopolsky et al., 2004b; Tarnopolsky and Parise, 1999; Terjung et al., 2000), there may be theoretical benefits in these groups of patients.”
BackgroundInfluentialSelf-citationIsenberg, D. A., Allen, E., Farewell, V., Ehrenstein, M. R., Hanna, M. G., Lundberg, I. E., Oddis, C., Pilkington, C., Plotz, P., Scott, D., et al. (2004) · Rheumatology · doi:10.1093/rheumatology/keg427 · Cited by 368 · cited 1×
“At the current time, inclusion body myositis is resistant to any immunosuppressive therapy, and the only intervention that has shown any benefit is resistance exercise training (Alexanderson, 2005; Arnardottir et al., 2003; Isenberg et al., 2004).”
BackgroundDuchenne muscular dystrophy: Patterns of clinical progression and effects of supportive therapy
Brooke, M. H., Fenichel, G. M., Griggs, R. C., Mendell, J. R., Moxley, R., Florence, J., King, W. M., Pandya, S., Robison, J., Schierbecker, J., et al. (1989) · Neurology · doi:10.1212/wnl.39.4.475 · Cited by 353
Casey, A., Constantin-Teodosiu, D., Howell, S., Hultman, E., & Greenhaff, P. L. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.1.e31 · Cited by 343 · cited 1×
“, an increase in repetitive high intensity activity) (Casey et al., 1996; Mihic et al., 2000) have been reported in these patients; however, whether this translates into functional improvement and long-term benefit remains to be seen.”
Background
Research works printed but not linked: 2
- Park, J.H., Niermann, K.J., Ryder, N.M., Nelson, A.E., Das, A., Lawton, A.R., Hernanz-Schulman, M., and Olsen, N.J., 2000, Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum. 43: 2359–2367. · doi:10.1002/1529-0131(200010)43:10<2359::aid-anr25>3.0.co;2-d
- Tarnopolsky, M.A., Roy, B.D., and MacDonald, J.R., 1997, A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 20: 1502–1509. · DOI · Paper page
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“known for a long time that creatine supplementation possesses neuroprotective benefits [29, 38, 40, 136].”
BackgroundThe creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
“In particular, the neuroprotective role of Cr that is relevant to a number of neuromuscular and neuro-degenerative diseases is well documented (Matthews et al. 1998; Klivenyi et al. 1999; Brewer and Wallimann 2000; Wyss and Kaddurah-Daouk 2000; Baker and Tarnopolsky 2003; Andres et al. 2005a, b; Brosnan and Brosnan 20…”
BackgroundInfluentialAntonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00412-w · Cited by 345
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
“It is well known that creatine supplementation increases brain bioenergetics [21,166, 215,235,255,256] and has neuroprotective benefits, particularly in response to injury and/or ischemic conditions [58,64,66,257].”
BackgroundCharcot-Marie-Tooth: From Molecules to Therapy
Morena, J., Gupta, A., & Hoyle, J. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143419 · Cited by 206
“In addition to exercise, creatine supplementation has been tested in CMT; however, with inconsistent results [36,44,45].”
Result
Metadata
- Authors
- Tarnopolsky, M. A.
- Affiliations
- McMaster University Medical Centre (CA)
- Corresponding author
- Tarnopolsky, Mark A.
- ORCID
- Tarnopolsky, Mark A.
- Venue
- Subcellular Biochemistry
- Publisher
- Springer Netherlands
- Published
- 2007
- Volume
- 46
- Pages
- 183-204
- ISSN
- 0306-0225 (ISSN-L)
- OpenAlex
- W105472176
- Cited by
- 67
- References
- 94
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 5 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 6 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 3
- FWCI
- 10.16
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Sub-cellular biochemistry/Subcellular biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- creatine monohydrate supplementation, neuromuscular disorders, neurometabolic disorders, Duchenne muscular dystrophy, Becker muscular dystrophy, myotonic dystrophy, Charcot-Marie-Tooth disease, mitochondrial disease, McArdle disease, myophosphorylase deficiency, steroid myopathy, myositis, myoadenylate deaminase deficiency, fatty acid oxidation disorders, mitochondrial function, intracellular calcium, fat-free mass, bone health, exercise capacity, oxidative stress
- MeSH terms
- Animals, Body Composition, Charcot-Marie-Tooth Disease, Creatine, Disease Models, Animal, Glycogen Storage Disease Type V, Humans, Physical Endurance, Mice, Inbred mdx, Muscular Dystrophy, Duchenne, Mitochondrial Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders. https://app.cochat.ai/papers/10.1007/978-1-4020-6486-9_10
- The paper
- Tarnopolsky, M. A. (2007). Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders. Subcellular Biochemistry. https://doi.org/10.1007/978-1-4020-6486-9_10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.